Blog
RSS FeedPosted by Michael Wonder on 05 Feb 2023
Amazon’s RxPass doesn’t yet really compete with Mark Cuban’s Cost Plus Drug Company
3 February 2023 - Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug ...
Posted by Michael Wonder on 02 Feb 2023
‘Enough sickness’ to share GP load among pharmacists, nurses
2 February 2023 - Pharmacy Guild of Australia president Trent Twomey says there is enough “demand and sickness” to allow ...
Posted by Michael Wonder on 31 Jan 2023
Distribution markups and taxes for prescription pharmaceuticals: do we see the complete picture of the pharmaceutical price?
30 January 2023 - An analysis presented at the ISPOR Europe 2021 conference highlighted considerable variability across countries in how much ...
Posted by Michael Wonder on 30 Jan 2023
Amazon’s bold $5 prescription drug program is the future of pharmacy
28 January 2023 - Amazon is taking yet another bold step into the world of health care, further solidifying its powerful ...
Posted by Michael Wonder on 24 Jan 2023
Introducing RxPass from Amazon Pharmacy, a $5 prescription subscription that helps Prime members who take multiple medications save time and money
24 January 2023 - In addition to all the savings, convenience, and entertainment they already enjoy, Prime members can now receive ...
Posted by Michael Wonder on 10 Jan 2023
Pharmacy benefit managers and the Federal Trade Commission: a relationship gone sour
9 January 2023 - On 7 June 2022, the Federal Trade Commission announced its decision to launch an inquiry into the ...
Posted by Michael Wonder on 22 Nov 2022
Mark Cuban has taken on pharmacy benefit managers and forever disrupted healthcare in America
19 November 2022 - Imagine finding out that there is a drug on the market for your terminal disease. ...
Posted by Michael Wonder on 12 Nov 2022
NSW pharmacists to prescribe the pill, antibiotics in health shake-up
13 November 2022 - Pharmacists will be able to prescribe a range of meds and repeat scripts under a NSW government ...
Posted by Michael Wonder on 19 Sep 2022
Pharmacists can now prescribe Paxlovid, but barriers persist
19 September 2022 - Recently, the FDA expanded access to COVID-19 treatment by authorising state-licensed pharmacists to prescribe Paxlovid to eligible ...
Posted by Michael Wonder on 06 Aug 2022
New Zealand allowed pharmacists to dispense COVID-19 antivirals and 'everyone realised it was a win'
6 August 2022 - With Australians dying from COVID-19 every day and nearly 5,000 people in hospital with the disease, experts ...
Posted by Michael Wonder on 04 Aug 2022
Panicked patients as popular medications get wiped from pharmacy shelves
4 August 2022 - Widely used medications — including one used to treat ADHD — are missing from Australian shelves amid ...
Posted by Michael Wonder on 06 Jul 2022
FDA authorises pharmacists to prescribe Paxlovid with certain limitations
6 July 2022 - New prescribing authority could improve access for some patients at high risk for severe COVID-19. ...
Posted by Michael Wonder on 03 Jul 2022
Drug manufacturers are root cause of high drug costs; PBMs drive costs down
30 June 2022 - It should come as no surprise that pharmacy benefit managers applaud Congress for recent bipartisan action to ...
Posted by Michael Wonder on 03 Jul 2022
FTC goes after PBMs, warns of legal action
2 July 2022 - Last month, the Federal Trade Commission voted unanimously (5-0) to examine rising list prices of insulin, but ...
Posted by Michael Wonder on 30 Jun 2022
Update to continued dispensing arrangements
30 June 2022 - From 1 July 2022, on-going continued dispensing arrangements have been expanded to include additional medicines groups to ...